Literature DB >> 10344361

Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine.

K Katai1, H Tanaka, S Tatsumi, Y Fukunaga, K Genjida, K Morita, N Kuboyama, T Suzuki, T Akiba, K Miyamoto, E Takeda.   

Abstract

BACKGROUND: We recently reported that the administration of niceritorol (a nicotinic acid derivative which improves lipid metabolism and peripheral circulation, and is used for the treatment of hyperlipidaemia and impaired peripheral circulation) to patients with hyperphosphataemia undergoing dialysis decreased the serum phosphate (Pi) concentration. We found that this was due to an acceleration of faecal Pi excretion by niceritrol.
METHODS: Intestinal brush border membrane vesicles (BBMVs) were prepared from rat jejunum, and the Na+-dependent and Na+-independent Pi transport activities in these vesicles were measured. In addition, the functional Pi transporter from rat small intestine was injected in Xenopus oocytes, and the effect of nicotinamide on the levels of its expression were measured by northern blotting.
RESULTS: The Na+-dependent component was significantly decreased in the BBMVs isolated from rats treated with nicotinamide, while the Na+-independent component was not changed. Kinetic studies demonstrated that the decreased activity was due to reduction of the Vmax value and not an elevation of the Km values. When poly(A)+RNA from rats treated with nicotinamide was microinjected into Xenopus oocytes, the Pi transport activity was significantly decreased compared with that in the control animals. In addition, there were no significant changes in Na/Pi cotransporters and activators, but the vitamin D receptor mRNA level was reduced to 80% of the control level.
CONCLUSIONS: These observations suggest that nicotinamide may regulate the expression of a major functional Na/Pi cotransporter in the rat small intestine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344361     DOI: 10.1093/ndt/14.5.1195

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  45 in total

1.  Effect of niacin on FGF23 concentration in chronic kidney disease.

Authors:  Madhumathi Rao; Michael Steffes; Andrew Bostom; Joachim H Ix
Journal:  Am J Nephrol       Date:  2014-05-20       Impact factor: 3.754

2.  Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Authors:  Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A Hanlon; Andrew G Bostom
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  Intestinal phosphate absorption: The paracellular pathway predominates?

Authors:  Matthew Saurette; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-14

Review 4.  Control of phosphate balance by the kidney and intestine.

Authors:  Ichiro Kaneko; Sawako Tatsumi; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2016-11-30       Impact factor: 2.801

5.  Npt2b deletion attenuates hyperphosphatemia associated with CKD.

Authors:  Susan C Schiavi; Wen Tang; Christina Bracken; Stephen P O'Brien; Wenping Song; Joseph Boulanger; Susan Ryan; Lucy Phillips; Shiguang Liu; Cynthia Arbeeny; Steven Ledbetter; Yves Sabbagh
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

Review 6.  Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis.

Authors:  Yuan-Mei He; Li Feng; Dong-Mei Huo; Zhen-Hua Yang; Yun-Hua Liao
Journal:  Int Urol Nephrol       Date:  2013-10-11       Impact factor: 2.370

Review 7.  Regulation of renal phosphate handling: inter-organ communication in health and disease.

Authors:  Sawako Tatsumi; Atsumi Miyagawa; Ichiro Kaneko; Yuji Shiozaki; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2015-08-22       Impact factor: 2.626

8.  The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

Authors:  Rakesh Malhotra; Ronit Katz; Andrew Hoofnagle; Andrew Bostom; Dena E Rifkin; Ruth Mcbride; Jeffrey Probstfield; Geoffrey Block; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2017-12-05       Impact factor: 8.237

9.  All-trans retinoic acid reduces the transcriptional regulation of intestinal sodium-dependent phosphate co-transporter gene (Npt2b).

Authors:  Masashi Masuda; Hironori Yamamoto; Yuichiro Takei; Otoki Nakahashi; Yuichiro Adachi; Kohta Ohnishi; Hirokazu Ohminami; Hisami Yamanaka-Okumura; Hiroshi Sakaue; Makoto Miyazaki; Eiji Takeda; Yutaka Taketani
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

10.  A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.

Authors:  Steven C Cheng; Daniel O Young; Yihung Huang; James A Delmez; Daniel W Coyne
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.